These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9478300)

  • 41. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma.
    Creutzberg CL; van Putten WL; Koper PC; Lybeert ML; Jobsen JJ; Wárlám-Rodenhuis CC; De Winter KA; Lutgens LC; van den Bergh AC; van de Steen-Banasik E; Beerman H; van Lent M
    Lancet; 2000 Apr; 355(9213):1404-11. PubMed ID: 10791524
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adjuvant radiotherapy in Stage II endometrial carcinoma: Is brachytherapy alone sufficient for local control?
    Paydar I; DeWees T; Powell M; Mutch DG; Grigsby PW; Schwarz JK
    Brachytherapy; 2015; 14(4):427-32. PubMed ID: 25911995
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Chemotherapy and rectal cancer].
    Michel P; Di Fiore F
    Cancer Radiother; 2011 Oct; 15(6-7):436-9. PubMed ID: 21885319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of outcomes in surgically staged I/II endometrial adenocarcinoma patients treated with postoperative vaginal vault radiotherapy only.
    Eiriksson L; Cuartero J; Steed H; Pearcey R; Capstick V; Schepansky A; Faught W; Dundas G
    Int J Gynecol Cancer; 2010 Nov; 20(8):1356-62. PubMed ID: 21051977
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In Vitro Adenosine Triphosphate-Based Chemotherapy Response Assay as a Predictor of Clinical Response to Fluorouracil-Based Adjuvant Chemotherapy in Stage II Colorectal Cancer.
    Kwon HY; Kim IK; Kang J; Sohn SK; Lee KY
    Cancer Res Treat; 2016 Jul; 48(3):970-7. PubMed ID: 26511802
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathology of rectal adenocarcinoma following preoperative adjuvant radiotherapy and chemotherapy.
    Allen DC; Fon LJ; McAleer JJ; Irwin ST
    Ulster Med J; 1999 May; 68(1):17-21. PubMed ID: 10489807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The vaginal stump recurrence rate in endometrial carcinoma in relation to the target volume of postoperative HDR-afterloading brachytherapy].
    Kloetzer KH; Günther R; Wendt T
    Strahlenther Onkol; 1997 Jan; 173(1):13-7. PubMed ID: 9082580
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intraperitoneal chemotherapy: biologic implications for clinical outcome.
    Daly JM
    Ann Surg; 2000 Apr; 231(4):457-9. PubMed ID: 10749604
    [No Abstract]   [Full Text] [Related]  

  • 49. A multicenter analysis of adjuvant therapy after surgery for stage IIIC endometrial adenocarcinoma: A Korean Radiation Oncology Group study (KROG 13-17).
    Yoon MS; Park W; Huh SJ; Kim HJ; Kim YS; Kim YB; Kim JY; Lee JH; Kim HJ; Cha J; Kim JH; Kim J; Yoon WS; Choi JH; Chun M; Choi Y; Chang SK; Lee KK; Kim M
    Gynecol Oncol; 2015 Sep; 138(3):519-25. PubMed ID: 26115977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group.
    Klinkenbijl JH; Jeekel J; Sahmoud T; van Pel R; Couvreur ML; Veenhof CH; Arnaud JP; Gonzalez DG; de Wit LT; Hennipman A; Wils J
    Ann Surg; 1999 Dec; 230(6):776-82; discussion 782-4. PubMed ID: 10615932
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach.
    Kim S; Lim DH; Lee J; Kang WK; MacDonald JS; Park CH; Park SH; Lee SH; Kim K; Park JO; Kim WS; Jung CW; Park YS; Im YH; Sohn TS; Noh JH; Heo JS; Kim YI; Park CK; Park K
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1279-85. PubMed ID: 16099596
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early results from a phase I/II radiation dose-escalation study with concurrent amifostine and infusional 5-fluorouracil chemotherapy for preoperative treatment of unresectable or locally recurrent rectal carcinoma.
    Myerson R; Zobeiri I; Birnbaum E; Dietz D; Fleshman J; Kodner I; Picus J; Ratkin G
    Semin Oncol; 2002 Dec; 29(6 Suppl 19):29-33. PubMed ID: 12577240
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adenocarcinoma of the endometrium treated with combined irradiation and surgery: study of 437 patients.
    Touboul E; Belkacémi Y; Buffat L; Deniaud-Alexandre E; Lefranc JP; Lhuillier P; Uzan S; Jannet D; Uzan M; Antoine M; Huart J; Ganansia V; Milliez J; Blondon J; Housset M; Schlienger M
    Int J Radiat Oncol Biol Phys; 2001 May; 50(1):81-97. PubMed ID: 11316550
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma.
    Keene KS; Rich TA; Penberthy DR; Shepard RC; Adams R; Jones RS
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):97-103. PubMed ID: 15850908
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemoradiation for localized pancreatic cancer: another perspective.
    Evans DB; Abbruzzese JL
    Ann Surg Oncol; 1999; 6(1):4-7. PubMed ID: 10030405
    [No Abstract]   [Full Text] [Related]  

  • 56. Radiation and chemotherapy instead of surgery for low infiltrative rectal adenocarcinoma: a prospective trial.
    Rossi BM; Nakagawa WT; Novaes PE; Filho WD; Lopes A
    Ann Surg Oncol; 1998 Mar; 5(2):113-8. PubMed ID: 9527263
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma.
    Leong CN; Chung HT; Lee KM; Shakespeare TP; Mukherjee RK; Wong LC; Lu JJ; Tey J; Lim R; So JB; Back MF
    Cancer J; 2008; 14(4):269-75. PubMed ID: 18677137
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adjuvant vaginal brachytherapy decreases the risk of vaginal recurrence in patients with stage I non-invasive uterine papillary serous carcinoma. A multi-institutional study.
    Mahdi H; Rose PG; Elshaikh MA; Munkarah A; Isrow D; Singh S; Waggoner S; Ali-Fehmi R; Morris RT; Harding J; DeBenardo R
    Gynecol Oncol; 2015 Mar; 136(3):529-33. PubMed ID: 25575483
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adjuvant chemotherapy in curative resected colon carcinoma: 5-fluorouracil/leucovorin versus high-dose 5-fluorouracil 24-h infusion/leucovorin versus high-dose 5-fluorouracil 24-h infusion.
    Arkenau HT; Rettig K; Porschen R
    Int J Colorectal Dis; 2005 May; 20(3):258-61. PubMed ID: 15549327
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study.
    Keys HM; Roberts JA; Brunetto VL; Zaino RJ; Spirtos NM; Bloss JD; Pearlman A; Maiman MA; Bell JG;
    Gynecol Oncol; 2004 Mar; 92(3):744-51. PubMed ID: 14984936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.